文献速递基层心理健康预防保健、筛查与疫苗慢病管理

基层医疗中精神治疗药物处方误用筛查:两种工具的比较

Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments.
PubMed 文献 · J Am Board Fam Med · 2019-01-01

本研究在服务不足的城市诊所的基层医疗患者中,通过匿名计算机健康筛查比较了RxCAGE和POMI-e两种筛查工具对处方精神治疗药物误用的识别情况。在2339名受访者中,15.3%的RxCAGE和18.6%的POMI-e筛查阳性;以计算机健康筛查为参照,POMI-e的曲线下面积较高(0.63)。两种工具均显示出作为筛查工具的潜力,未来需在更广泛人群中验证并试点干预。

要点

  • 在基层医疗患者中,处方精神治疗药物误用率较高,RxCAGE阳性率15.3%,POMI-e阳性率18.6%。
  • 以计算机健康筛查为参照,POMI-e的曲线下面积(AUC)为0.63,高于RxCAGE。
  • POMI-e阳性与男性、白人、失业、抑郁焦虑、当前使用非法物质、吸烟及酒精误用相关。

核心结论

  • 处方精神治疗药物误用在基层医疗中较为普遍,RxCAGE和POMI-e两种筛查工具均显示出应用前景。

研究设计与样本

  • 研究纳入某健康系统内服务不足的城市诊所的基层医疗患者,完成匿名计算机健康筛查,并同时接受RxCAGE和POMI-e两种筛查问卷,共2339名受访者。

主要发现

  • 2339名受访者中,15.3%的RxCAGE筛查阳性(至少2项阳性),18.6%的POMI-e筛查阳性(至少2项阳性)。
  • 以计算机健康筛查为参照,POMI-e的曲线下面积(AUC)为0.63。
  • POMI-e阳性与男性、白人、失业、抑郁和焦虑、当前使用非法物质、吸烟及酒精误用相关。

关键数值与推荐

  • RxCAGE为4条目问卷,修改为针对处方药物,至少2项阳性定义为筛查阳性。
  • POMI-e为6条目处方阿片类药物误用指数扩展版,纳入其他处方药物,至少2项阳性定义为筛查阳性。

临床怎么用

  • 基层医疗中可考虑使用RxCAGE或POMI-e对处方精神治疗药物误用进行常规筛查,其中POMI-e在本研究中的判别能力较高。
  • 对POMI-e筛查阳性的患者,应关注其男性、白人、失业、抑郁焦虑、非法物质使用、吸烟及酒精误用等相关特征。

局限性

  • 研究人群限于服务不足的城市诊所基层医疗患者,结果外推需谨慎。
  • 原文未报告筛查工具的灵敏度、特异度等完整心理测量学指标。
  • 原文指出未来需要在更广泛人群中测试筛查工具并试点干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Prescription psychotherapeutic medication misuse is a growing problem in the United States, but no method exists to routinely screen for this in primary care. Our study sought to (1) describe the prevalence of prescription psychotherapeutic medication misuse in primary care and the characteristics of patients who misuse and (2) compare 2 screening instruments modified to identify prescription medication misuse in primary care. METHODS: Primary care patients from underserved, urban clinics within a health system completed anonymous computer-directed health screens that included standard questions about prescription medication misuse. They were also administered the 4-item Cut down, Annoyed, Guilty, and Eye-opener questionnaire modified to focus on prescription medications (RxCAGE) and a 6-item Prescription Opioid Misuse Index (POMI-e) expanded to include other prescription medications. RESULTS: Of 2,339 respondents, 15.3% were positive for at least 2 items on the RxCAGE and 18.6% were positive for at least 2 items on the POMI-e. Using our computer-directed health screen as a comparison, we found that POMI-e had a higher area under the curve (0.63). A positive POMI-e was associated with being male, white and unemployed, having depression and anxiety, and currently using illicit substances, smoking, and misusing alcohol. CONCLUSIONS: Rates of prescription medication misuse were substantial with both RxCAGE and POMI-e showing promise as screening instruments. Future studies are needed to test prescription medication misuse screening tools in broader populations and pilot interventions for those screening positive.

来源:J Am Board Fam Med,查看原文。版权归原作者所有。

引用

  1. Tong ST, Polak KM, Weaver MF, et al. Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments. J Am Board Fam Med. 2019. PMID: 30850465. doi:10.3122/jabfm.2019.02.180172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。